Evolution of virulence in epidemic community-associated methicillin-resistant <i>Staphylococcus aureus</i>

  • Min Li
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, Hamilton, MT 59840, and 9000 Rockville Pike, Bethesda, MD 20892;
  • Binh An Diep
    Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, 1001 Potrero Avenue, Box 0811, San Francisco, CA 94110
  • Amer E. Villaruz
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, Hamilton, MT 59840, and 9000 Rockville Pike, Bethesda, MD 20892;
  • Kevin R. Braughton
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, Hamilton, MT 59840, and 9000 Rockville Pike, Bethesda, MD 20892;
  • Xiaofei Jiang
    Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, 12 Central Urumqi Road, Shanghai 200040, People's Republic of China; and
  • Frank R. DeLeo
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, Hamilton, MT 59840, and 9000 Rockville Pike, Bethesda, MD 20892;
  • Henry F. Chambers
    Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, 1001 Potrero Avenue, Box 0811, San Francisco, CA 94110
  • Yuan Lu
    Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, 12 Central Urumqi Road, Shanghai 200040, People's Republic of China; and
  • Michael Otto
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, Hamilton, MT 59840, and 9000 Rockville Pike, Bethesda, MD 20892;

書誌事項

公開日
2009-04-07
DOI
  • 10.1073/pnas.0900743106
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p> Community-associated methicillin-resistant <jats:italic>Staphylococcus aureus</jats:italic> (CA-MRSA) has recently emerged worldwide. The United States, in particular, is experiencing a serious epidemic of CA-MRSA that is almost entirely caused by an extraordinarily infectious strain named USA300. However, the molecular determinants underlying the pathogenic success of CA-MRSA are mostly unknown. To gain insight into the evolution of the exceptional potential of USA300 to cause disease, we compared the phylogeny and virulence of USA300 with that of closely related MRSA clones. We discovered that the sublineage from which USA300 evolved is characterized by a phenotype of high virulence that is clearly distinct from other MRSA strains. Namely, USA300 and its progenitor, USA500, had high virulence in animal infection models and the capacity to evade innate host defense mechanisms. Furthermore, our results indicate that increased virulence in the USA300/USA500 sublineage is attributable to differential expression of core genome-encoded virulence determinants, such as phenol-soluble modulins and α-toxin. Notably, the fact that the virulence phenotype of USA300 was already established in its progenitor indicates that acquisition of mobile genetic elements has played a limited role in the evolution of USA300 virulence and points to a possibly different role of those elements. Thus, our results highlight the importance of differential gene expression in the evolution of USA300 virulence. This finding calls for a profound revision of our notion about CA-MRSA pathogenesis at the molecular level and has important implications for design of therapeutics directed against CA-MRSA. </jats:p>

収録刊行物

被引用文献 (7)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ